Fecal microbiota transplantation has gained growing scientific attention in numerous research areas, thanks to the increasing evidence supporting its effectiveness. In this review, we summarize the most relevant updates in the field of FMT published in the last year, covering various clinical areas, including Clostridioides difficile infection, inflammatory bowel disease, irritable bowel syndrome, diabetes, metabolic syndrome, and liver disease.
To cite this article
Update on fecal microbiota transplantation
Microb Health Dis 2023;
Submission date: 26 Aug 2023
Revised on: 29 Aug 2023
Accepted on: 08 Sep 2023
Published online: 17 Oct 2023
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.